The FDA apparently deems an uncontrolled study acceptable – five months after saying no.
ApexOnco Front Page
Recent articles
Could RO7851624, newly into clinical trials, be RG6735?
A single but durable stable disease sends the microcap's stock up 730%.
MK-8294 starts phase 1, but its mechanism is anybody's guess.
A newly published cache of CRLs includes six novel oncology drugs.
Autogene cevumeran goes on hold in adjuvant bladder cancer.
The deal for ISB 2001 is worth $700m up front.
Multispecifics newly into the clinic include Car-Ts from Essen and Unicar.